Menu Warning: Things Can Change Beware of Greenwashing Everything Natural isn't Safe, and Vice Versa Learn to Read the Labels Routes of Exposure Pollution in People Nanoparticles - Something New to Watch Out For Essential ...
Tags: Baby Products, Pollution, Nanoparticles
Medical technology company Cyberonics has implanted 100,000th patient using its Vagus Nerve Stimulation (VNS) therapy system. Using implanted medical device, the CE-marked VNS therapy system delivers pulsed electrical signals to the vagus ...
Tags: Cyberonics, Vagus Nerve Stimulator, Health Medicine, Medical technology
Digital media has experienced a surge in popularity since it was first introduced to the general public. With mobile technology, streaming video, and other digital capabilities widely available, it is only natural that the entertainment ...
Tags: Digital media, mobile technology, streaming video, entertainment industry
FUTURE computing devices will push further into the senses by developing capacities to mimic the ability to see, smell, touch, taste and hear, IBM says in an annual forecast. The seventh annual "IBM 5 in 5", a list of innovations that ...
Tags: IBM, Computing Devices, Computer P, Consumer Electronics
Los Angeles-based NeuroSigma, a developer of early stage neuromodulation technologies, has won ISO 13485: 2003 certification. The certificate indicates that the company meets the quality standards to design, and manufacture its external ...
Tags: NeuroSigma, neuromodulation technologies, ISO certification, eTNS
Israel's Ministry of Health has granted an approval to Brainsway to conduct a trial to test the efficacy of Deep Transcranial Magnetic Stimulation (TMS) system in treating autism in children with low functionality levels. Brainsway TMS ...
Eisai has received positive opinion from the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) for Fycompa (perampanel), an AMPA receptor antagonist. Fycompa (perampanel) is an adjunctive treatment of ...
Tags: fycompa, perampanel, epilepsy, zonisamide
Supernus Pharmaceuticals has received approval from the FDA for its Oxtellar XR, a new once-daily extended release formulation of oxcarbazepine. Oxtellar XR is an antiepileptic drug used as an adjunct therapy to treat partial seizures in ...
Tags: oxcarbazepine, FDA approval, partial seizure, pharmaceutical product
MedGenesis Therapeutix, a biotechnology company, has received a grant from the Deutsche Parkinson Vereinigung e.V. for the Phase II development of glial cell line derived neurotrophic factor (GDNF). MedGenesis chairman and CEO Dr. Erich ...
Tags: Advance Gdnf, MedGenesis Therapeutix, Parkinson's disease
Neurotech, a developer of active implantable devices, has received CE mark approval for its ADNS-300 to treat refractory epilepsy. The surgically implanted ADNS-300 system operates as a pacemaker to produce stimulation towards the brain ...
Tags: active implantable devices, Neurotech, refractory epilepsy
The US Food and Drug Administration (FDA) has approved Eisai's non-competitive AMPA glutamate receptor antagonist for patients who continue to have seizures despite being on other prescription medications for epilepsy. The drug, ...
NeuroSigma has obtained CE mark approval for its external Trigeminal Nerve Stimulation (eTNS) system, Monarch, designed for the treatment of epilepsy and major depressive disorder in adults and children of 9 years and older. The eTNS ...
Tags: NeuroSigma, eTNS, FDA
TWO million people in the UK face increased risk of health problems, campaigners have warned, following a European ban on incandescent bulbs starting today. While the move to energy-saving bulbs has been widely welcomed, there are ...
Tags: LED bulb, Incandescent bulb
A European ban on incandescent bulb takes effect in the UK since 1, September, despite the move to energy-saving bulbs has been widely welcomed, campaigners have warned that there are concerns about the impact on people who are sensitive to ...
Tags: Incandescent Bulb, LED bulb
Qualitest Pharmaceuticals, a generic pharmaceutical company, has won the US Food and Drug Administration (FDA) approval for abbreviated new drug application (ANDA) for Levetiracetam extended-release tablets, 500mg and 750mg. The ...